CHARGED ALPHA
Stock Detail
Stock Library / DXCM
DXCM Unclassified Latest YouTube: Q1 2026

DXCM

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Library coverage

Episodes tracked
1
Episodes linked
1
Latest video
Q1 2026
Podcast available
Yes
Current price
$72.10
+0.24 (+0.33%)
Trailing / Forward P/E
30.94x
Forward: 23.64x
Market cap / Volume
Volume:
Revenue / Earnings Growth
15.0%
Earnings: 92.2%
Margins
21.4% op
Gross: 61.5% · Net: 19.3%
Balance sheet
1.95x current
Debt / Equity: 46.8
52-week range / Beta
$54.11 - $89.98
Beta: 1.40
Analyst target
$81.64
Upside: 13.2%
Cash / shareholder return
3.80% FCF yield
Dividend yield: —

Company context

Industry: Medical Devices
Country: United States
Employees:
Price to book: 9.41x
Return on equity: 35.6%
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Price chart

Market context for DXCM

Competitive view

DXCM vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

DXCM
DXCM
YouTube
Latest video
Q1 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation sits in a middle zone where future upside likely depends more on quarterly execution than on multiple re-rating alone.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
SS&C Technologies Holdings Inc.
SSNC
YouTube
Latest video
Q1 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.
Charles Schwab Corporation
SCHW
YouTube
Latest video
Q1 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.
Market Cap
More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.
DXCM
$27.82B
DXCM
SSNC
$16.15B
SS&C Technologies Holdings Inc.
SCHW
$156.78B
Charles Schwab Corporation
Trailing P/E
Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.
DXCM
30.9x
DXCM
SSNC
20.8x
SS&C Technologies Holdings Inc.
SCHW
17.9x
Charles Schwab Corporation
Forward P/E
Forward P/E is often a better read on what investors are paying for the next year of earnings power.
DXCM
23.6x
DXCM
SSNC
8.9x
SS&C Technologies Holdings Inc.
SCHW
12.5x
Charles Schwab Corporation
Revenue Growth
Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.
DXCM
15.0%
DXCM
SSNC
8.8%
SS&C Technologies Holdings Inc.
SCHW
15.8%
Charles Schwab Corporation
Earnings Growth
Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.
DXCM
92.2%
DXCM
SSNC
8.3%
SS&C Technologies Holdings Inc.
SCHW
38.6%
Charles Schwab Corporation
Operating Margin
Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.
DXCM
21.4%
DXCM
SSNC
24.2%
SS&C Technologies Holdings Inc.
SCHW
49.4%
Charles Schwab Corporation
Gross Margin
Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.
DXCM
61.5%
DXCM
SSNC
48.0%
SS&C Technologies Holdings Inc.
SCHW
97.5%
Charles Schwab Corporation
Net Margin
Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.
DXCM
19.3%
DXCM
SSNC
12.7%
SS&C Technologies Holdings Inc.
SCHW
38.0%
Charles Schwab Corporation
Return on Equity
ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.
DXCM
35.6%
DXCM
SSNC
11.8%
SS&C Technologies Holdings Inc.
SCHW
19.1%
Charles Schwab Corporation
Free Cash Flow Yield
Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.
DXCM
3.8%
DXCM
SSNC
7.9%
SS&C Technologies Holdings Inc.
SCHW
6.2%
Charles Schwab Corporation
Debt to Equity
Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.
DXCM
46.83x
DXCM
SSNC
110.67x
SS&C Technologies Holdings Inc.
SCHW
120.77x
Charles Schwab Corporation
Current Ratio
A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.
DXCM
1.95x
DXCM
SSNC
1.10x
SS&C Technologies Holdings Inc.
SCHW
0.63x
Charles Schwab Corporation
Beta
Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.
DXCM
1.40
DXCM
SSNC
1.12
SS&C Technologies Holdings Inc.
SCHW
0.80
Charles Schwab Corporation
Dividend Yield
Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.
DXCM
DXCM
SSNC
1.6%
SS&C Technologies Holdings Inc.
SCHW
1.2%
Charles Schwab Corporation
Analyst Upside
Higher analyst upside suggests the Street still sees room between current price and consensus fair value.
DXCM
13.2%
DXCM
SSNC
41.4%
SS&C Technologies Holdings Inc.
SCHW
28.5%
Charles Schwab Corporation

Episode timeline

Episode archive for DXCM

Each row is one earnings episode with every verified platform link available.

Q1 2026
Episode live
Published youtube podcast complete
DXCM Stock: Q1 2026 Earnings Analysis
Quarterly earnings-analysis entry for DXCM. Use the links on the right to open the video or podcast episode.